Publication | Open Access

Dihydromyricetin protects against cerebral ischemia/reperfusion injury via suppressing microglia-mediated neuroinflammation and activation of ERK1/2-CREB signaling pathway

InflammationMedicineMicroglia-mediated NeuroinflammationPharmacologyCell DeathCerebral Ischemia/reperfusion InjuryNeuroprotectionNeuroscienceBrain InjuryNeurologyCerebral Blood FlowReperfusion InjuryNeuroimmunologyIschemic SyndromeOxidative StressNeuroinflammation